Abstract

The Role of Biologics in Managing Systemic Lupus Erythematosus: Current Challenges and Future Directions

Author(s): Ralley E Prentice*

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by widespread inflammation and multi-organ involvement. The pathogenesis of SLE involves the abnormal activation of the immune system, leading to the production of autoantibodies that attack various tissues, including the skin, kidneys, heart, and joints. As a result, patients with SLE often experience a wide range of symptoms, including fatigue, joint pain, skin rashes, and kidney dysfunction, which can significantly impair their quality of life.


PDF